Prkar1a in the regulation of insulin secretion

Hormone and Metabolic Research

Volumn 44, Issue 10, 2012, Pages 759-765

  Hussain, M A ^a   Stratakis, C ^b   Kirschner, L ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b National Institute of Child Health and Disease   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

insulin secretion; Prkar1a; type 2 diabetes

Indexed keywords

ADAPTOR PROTEIN; CYCLIC AMP BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; EXCHANGE PROTEIN ACTIVATED BY CYCLIC AMP; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INCRETIN; PROTEIN SNAPIN; SNARE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG;

CARNEY COMPLEX; CELL MEMBRANE; EXOCYTOSIS; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INTRACELLULAR SIGNALING; INTRAVENOUS GLUCOSE TOLERANCE TEST; NERVE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SECRETORY VESICLE;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; DIABETES MELLITUS; EXOCYTOSIS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; VESICULAR TRANSPORT PROTEINS;

EID: 84865639754     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1321866     Document Type: Review

References (19)

1. Nolan C J, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet: 2011; 378 169 181
2. Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev: 2001; 17 164 174
3. Gerich J E. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes: 2002; 51 01 S117 S121
4. Lillioja S, Mott D M, Howard B V, Bennett P H, Yki-Jarvinen H, Frimond D, Nyomba B L, Zurlo F, Swinburn B, Bogardus C. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med: 1988; 318 1217 1225
5. Vaag A, Henriksen J E, Madsbad S, Holm N, Beck-Nielsen H. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest: 1995; 95 690 698
6. Ward W K, Bolgiano D C, McKnight B, Halter J B, Porte D Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest: 1984; 74 1318 1328
7. Egan J M, Clocquet A R, Elahi D. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab: 2002; 87 1282 1290
8. Fehse F, Trautmann M, Holst J J, Halseth A E, Nanayakkara N, Nielsen L L, Fineman M S, Kim D D, Nauck M A. Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab: 2005; 90 5991 5997
9. Drucker D J. The biology of incretin hormones. Cell Metab: 2006; 3 153 165
10. Drucker D J, Nauck M A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet: 2006; 368 1696 1705
11. Petyuk V A, Qian W J, Hinault C, Gritsenko M A, Singhal M, Monroe M E, Camp D G 2nd, Kulkarni R N, Smith R D. Characterization of the mouse pancreatic islet proteome and comparative analysis with other mouse tissues. J Proteome Res: 2008; 7 3114 3126
12. Chheda M G, Ashery U, Thakur P, Rettig J, Sheng Z H. Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex. Nat Cell Biol: 2001; 3 331 338
13. Fukui K, Yang Q, Cao Y, Takahashi N, Hatakeyama H, Wang H, Wada J, Zhang Y, Marselli L, Nammo T, Yoneda K, Onishi M, Hagashiyama S, Matsuzawa Y, Gonzalez F J, Weir G C, Kasai H, Shimomura I, Miyagawa J, Wollheim C B, Yamagata K. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab: 2005; 2 373 384
14. Copeland R J, Bullen J W, Hart G W. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab: 2008; 295 E17 E28
15. Akimoto Y, Hart G W, Wells L, Vosseller K, Yamamoto K, Munetomo E, Ohara-Imaizumi M, Nishiwaki C, Nagamatsu S, Hirano H, Kawakami H. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology: 2007; 17 127 140
16. Wang Z, Udeshi N D, Slawson C, Compton P D, Sakabe K, Cheung W D, Shabanowitz J, Hunt D E, Hart G W. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal: 2010; 3 ra2
17. Zeidan Q, Hart G W. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci: 2010; 123 13 22
18. Peyot M L, Pepin E, Lamontagne J, Latour M G, Zarrouki B, lussier R, Pineda M, Jetton T L, Madiraju S R, Joly E, Prentki M. Beta Cell Failure in Diet-Induced Obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta cell mass. Diabetes: 2010; 59 2178 2187
19. Song W J, Seshadri M, Ashraf U, Mdluli T, Mondal P, Keil M, Azevedo M, Kirschner L S, Stratakis C A, Hussain M A. Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab: 2011; 13 308 319